Icatibant Completed Phase 3 Trials for Angioedema Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00097695Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema